The main aim of Farhat Khanim’s research is the identification and delivery of effective, non-toxic therapies for blood cancers to the clinic. To achieve this goal, the group studies the basic biology of haematological malignancies, performs drug redeployment screening and drug mechanism of action studies. Mechanistic studies include analysis of tumour metabolism in response to drugs and tumour niche interactions.
Applicants who are interested in postgraduate projects with Dr Khanim should contact her directly with their CV and areas of particular interest.
1992 …2024
Research activity per year
Fingerprint
Dive into the research topics where Farhat Khanim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
